Clover Corporation Limited (ASX:CLV)

Australia flag Australia · Delayed Price · Currency is AUD
0.5250
-0.0250 (-4.55%)
Sep 15, 2025, 3:45 PM AEST
-4.55%
Market Cap91.85M
Revenue (ttm)72.49M
Net Income (ttm)4.53M
Shares Out167.00M
EPS (ttm)0.03
PE Ratio20.14
Forward PE13.89
Dividend0.02 (2.73%)
Ex-Dividend DateApr 9, 2025
Volume16,222
Average Volume82,773
Open0.5500
Previous Close0.5500
Day's Range0.5250 - 0.5650
52-Week Range0.3370 - 0.6000
Beta0.05
RSI40.23
Earnings DateSep 23, 2025

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm, a microencapsulated powders with the addition of Hi-DHA tuna and/or algal oils. Clover Corporation Limited was incorporated in 1988 and is headquartered in Alton... [Read more]

Founded 1988
Employees 60
Stock Exchange Australian Securities Exchange
Ticker Symbol CLV
Full Company Profile

Financial Performance

In 2024, Clover Corporation's revenue was 62.21 million, a decrease of -22.12% compared to the previous year's 79.88 million. Earnings were 1.52 million, a decrease of -75.58%.

Financial Statements

News

There is no news available yet.